Staphylococcus lugdunensis wall teichoic acid (Sl-WTA)

Staphylococcus lugdunensis wall teichoic acids (WTAs) are anionic glycopolymers covalently attached to the peptidoglycan of the bacterial cell wall. Unlike the ribitol-phosphate WTAs found in most Staphylococcus aureus strains, S. lugdunensis produces a poly(glycerol phosphate) backbone, which is typically modified with glucose and glucosamine residues (3.2.1, 3.2.3). These surface glycopolymers are essential for the bacterium's survival and virulence, playing key roles in maintaining cell wall integrity, regulating ion homeostasis, and mediating adhesion to host proteins such as fibronectin (2.2.1, 2.2.2). Sl-WTAs are particularly critical for the formation of biofilms, which contribute to the aggressive nature of S. lugdunensis infections, including infective endocarditis and prosthetic joint infections (2.4.1, 2.4.2). As a therapeutic target, WTAs offer opportunities for the development of novel antibiotics and antivirulence agents. Drugs like Targocil and Tunicamycin target the biosynthetic enzymes TarG and TarO, respectively, while others like Teixobactin bind to lipid-linked precursors to halt cell wall assembly (2.1.4, 2.3.2). Targeting these glycopolymers can also resensitize resistant strains to existing beta-lactam treatments by disrupting the coordination of cell wall synthesis (2.3.4). Given their accessibility on the cell surface and their role in host-pathogen interactions, Sl-WTAs are significant focal points for both diagnostic and therapeutic innovation in treating staphylococcal diseases.

Other names

Wall teichoic acidWTASurface glycopolymersPoly(glycerol phosphate) teichoic acidSl-WTA

Inhibition of wall teichoic acid biosynthesis (e.g., TarO or TarG inhibition), binding to cell wall precursors (Lipid II/III) to disrupt cell wall assembly, and electrostatic disruption of the cell envelope.